IRIS
RAIMONDO, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.483
EU - Europa 4.922
AS - Asia 994
SA - Sud America 19
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 3
AF - Africa 1
Totale 11.434
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.459
IE - Irlanda 1.587
SE - Svezia 1.391
CN - Cina 885
IT - Italia 544
UA - Ucraina 385
DE - Germania 273
PL - Polonia 214
FI - Finlandia 188
GB - Regno Unito 144
BE - Belgio 68
IN - India 67
FR - Francia 53
RU - Federazione Russa 28
VN - Vietnam 25
CA - Canada 23
AT - Austria 17
BR - Brasile 14
NZ - Nuova Zelanda 9
ES - Italia 6
IR - Iran 6
NL - Olanda 6
CL - Cile 4
AU - Australia 3
DK - Danimarca 3
EU - Europa 3
GR - Grecia 3
LV - Lettonia 3
BD - Bangladesh 2
ID - Indonesia 2
MY - Malesia 2
NO - Norvegia 2
RO - Romania 2
BG - Bulgaria 1
BY - Bielorussia 1
CH - Svizzera 1
HR - Croazia 1
IL - Israele 1
KW - Kuwait 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
PR - Porto Rico 1
SG - Singapore 1
TR - Turchia 1
VE - Venezuela 1
Totale 11.434
Salva come PNG Salva come JPEG
Città #
Dublin 1.587
Chandler 1.072
Nyköping 841
Jacksonville 833
Ashburn 480
Beijing 400
Messina 295
Ann Arbor 252
Princeton 246
Medford 223
Warsaw 210
Cambridge 188
Des Moines 179
Dearborn 144
Boardman 104
Woodbridge 85
Wilmington 80
Jinan 71
Brussels 68
Houston 67
San Mateo 58
Shenyang 54
Nanjing 53
New York 42
Hebei 38
Falls Church 36
Haikou 35
Pune 35
Seattle 34
Zhengzhou 28
Rome 26
Bremen 25
Tianjin 24
Hyderabad 23
Lancaster 23
Dong Ket 22
Ningbo 20
Nanchang 19
Los Angeles 18
Ottawa 18
Catania 17
Hangzhou 17
Vienna 17
Avola 15
Rosolini 15
Lanzhou 14
Norwalk 14
Guangzhou 13
Brasília 12
Changsha 12
Fuzhou 11
Auburn Hills 10
Taizhou 10
Jiaxing 9
Leawood 9
Washington 9
Augusta 8
Helsinki 8
Monmouth Junction 8
Palermo 8
Taiyuan 8
Pachino 7
Qingdao 7
Ardabil 6
Milan 6
Reggio Calabria 6
Tappahannock 6
Whakatane 6
Chengdu 5
Saint Petersburg 5
Clearwater 4
Madrid 4
Piazza Armerina 4
Radomsko 4
Redwood City 4
Strasbourg 4
Vittoria 4
Caltagirone 3
Chicago 3
Hefei 3
Kunming 3
Lappeenranta 3
Mountain View 3
Oxford 3
Redmond 3
San Filippo 3
Sortino 3
Stockholm 3
Trecastagni 3
Agios Dimitrios 2
Albino 2
Belpasso 2
Bến Tre 2
Cene 2
Culver City 2
Edinburgh 2
Frontone 2
Kharkov 2
Lamézia 2
London 2
Totale 8.440
Salva come PNG Salva come JPEG
Nome #
Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels. 268
PIVKA-II is a useful tool for diagnostic characterization of ultrasound-detected liver nodules in cirrhotic patients 127
Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. 125
Lack of the NS5B S282T mutation in HCV isolates from liver tissue of naive patients with HCV genotype-1b infection. 102
Acute kidney injury in cirrhotic patients undergoing contrast-enhanced computed tomography 102
Hepatitis B virus (HBV) markers and HBV-DNA in serum and liver tissue of patients with acute exacerbation of chronic type B hepatitis 96
Atrial fibrillation in patients with cirrhosis 94
Case Report: Atrial Fibrillation After Intravenous Administration of Iodinated Contrast Medium in a Patient With Hepatocellular Carcinoma 94
Does the margin width influence recurrence rate in liver surgery for hepatocellular carcinoma smaller than 5 cm? 93
Free episomal and integrated HBV DNA In HBsAg-negative patients with intrahepatic cholangiocarcinoma 92
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. 89
24th IFSO World Congress O-165 RISK FACTORS ASSOCIATED WITH NASH IN OBESE PATIENTS UNDERGOING BARIATRIC SURGERY 89
Hepatitis B virus and hepatitis C virus co-infection: additive players in chronic liver disease? 86
HBE ANTIBODY UNRELATED TO E-MINUS HEPATITIS-B VIRUS VARIANT INFECTION IN PATIENTS WITH CHRONIC TYPE-D HEPATITIS 85
Analysis of haemochromatosis gene mutations in a population from the Mediterranean Basin. 85
Evaluation of CTNNB1 and TP53 variability in patients with hepatocellular carcinoma and occult hepatitis B virus infection 85
The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. 83
Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases 81
Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. 80
Exacerbation of chronic liver disease due to hepatitis B surface antigen after delta infection. 80
Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease. 80
Is there a downgrading in the alert about the hepatitis B virus infection in Italy? 79
HEPATITIS-B VIRUS VARIANT, WITH A DELETION IN THE PRES2 AND 2 TRANSLATIONAL STOP CODONS IN THE PRECORE REGIONS, IN A PATIENT WITH HEPATOCELLULAR-CARCINOMA 78
NS3 Variability in Hepatitis C Virus Genotype 1A Isolates from Liver Tissue and Serum Samples of Treatment-Naïve Patients with Chronic Hepatitis C 78
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients 77
Update of the statements on biology and clinical impact of occult hepatitis B virus infection 75
Obesity and liver cancer 73
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis? 72
IPERTRANSAMINASEMIAQ PERSISTENTE IN UNA COORTE DI PAZIENTI DIABETICI DI TIPO 2: PREVALENZA E CORRELAZIONI CLINICHE. 72
null 70
Apolipoprotein AI-CIII-AIV genetic polymorphisms and coronary heart disease in type 2 diabetes mellitus 70
A GENETIC-POLYMORPHISM OF THE APOLIPOPROTEIN AI-CIII GENE- CLUSTER IS ASSOCIATED WITH CORONARY HEART-DISEASE IN NON- INSULIN-DEPENDENT DIABETES-MELLITUS 70
Ipertransaminasemia persistente in una coorte di pazienti diabetici di tipo 2: prevalenza e correlazioni cliniche 70
HCV NS5A mutations and response of chronic hepatitis to alpha interferon. 68
Effetto della menopausa sui livelli di omocisteina e sul polimorfismo C677T della metilenetetraidrofolato reduttasi nelle donne con diabete mellito di tipo 2 68
Expression of pre-S gene-encoded proteins in liver and serum during chronic hepatitis B virus infection in comparison to other markers of active virus replication 67
Premature ovarian senescence and a high miscarriage rate impair fertility in women with HCV 67
Occult HBV infection and suppression of HCV replication in the early phase of combination therapy for chronic hepatitis C 66
ALFA-INTERFERON TREATMENT INDUCES INSULIN AUTOANTIBODIES IN PATIENTS WITH CHRONIC VIRAL-HEPATITIS 66
Fibroscan: a new non-invasive method for evaluation of liver dysfunction in Turner syndrome 66
Interrupted replication of hepatitis B virus in liver tissue of HBsAg carriers with hepatocellular carcinoma 64
Elective endoscopic variceal ligation is not a risk factor for bacterial infection in patients with liver cirrhosis 64
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study 63
Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection 63
FULMINANT-HEPATITIS ASSOCIATED WITH THE INTRAFAMILIAR SPREAD OF A PRE-S2 DEFECTIVE HBV VARIANT AND THE LATE EMERGENCE OF HBEAG- MINUS VIRAL STRAINS 62
Radioimmunoassay detection of igm antibodies to the hbv-associated delta (δ) antigen: Clinical significance in δ infection 62
Dane particle-associated hepatitis B e antigen in patients with chronic hepatitis B virus infection and hepatitis B e antibody. 61
Mild hyperhomocysteinemia and the common C677t polymorphism of methylene tetrahydrofolate reductase gene are not associated with the metabolic syndrome in Type 2 diabetes. 61
A 2010 update on occult hepatitis B infection. 61
Analysis of occult hepatitis B virus infection in liver tissue of HIV patients with chronic hepatitis C. 60
A NEW HEPATITIS-B VIRUS VARIANT IN A CHRONIC CARRIER WITH MULTIPLE EPISODES OF VIRAL REACTIVATION AND ACUTE HEPATITIS 60
TT virus has a ubiquitous diffusion in human body tissues: analyses of paired serum and tissue samples. 59
Hypergammaglobulinemia is a strong predictor of disease progression, hepatocellular carcinoma, and death in patients with compensated cirrhosis. 59
Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. 59
Clinical virology of hepatitis B virus infection 58
Occult hepatitis B virus in liver tissue of individuals without hepatic disease. 58
Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection 58
BILE DUCTOPENIA FOLLOWING THERAPY WITH SULPIRIDE 58
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 (IL8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INTERFERON ALFA ANTIVIRAL ACTIVITY 58
HEPATITIS B VIRUS INDUCES INTERLEUKIN-8 N(IL-8) PRODUCTION IN HEPATOCYTES AND IL-8 IN TURN INHIBITS INERFERON ALFA ANTIVIRAL ACITIVITY 58
An evaluation of transient elastography in the discrimination of HBeAg-negative disease from inactive hepatitis B carriers 58
[A glance into the past ... Southern and northern blot: really superseded?] 58
Cirrhosis related to wild-type HBV infection in siblings with A3 - B35 - Cw4 HLA class I phenotype. 58
Replicative and transcriptional activities of hepatitis B virus in patients coinfected with hepatitis B and hepatitis delta viruses. 58
Response to the high diagnostic characteristics of HBsAg level in differentiation of Hepatitis B clinical presentations: myth or truth? 58
Variability of reverse transcriptase and overlapping S gene in hepatitis B virus isolates from untreated and lamivudine-resistant chronic hepatitis B patients. 57
Infection with HBV preS/S Variants is Highly Prevalent and Influences Amount of Circulating HBsAg Independently of Serum HBV DNA Levels and Response to Interferon Therapy in Chronic Hepatitis B 57
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 57
Frequency of somatic mutations in TERT promoter, TP53 and CTNNB1 genes in patients with hepatocellular carcinoma from Southern Italy 57
INTRAHEPATIC HDV RNA, HBV DNA, AND HBV RNAS QUANTIFICATIONS REVEAL SUPPRESSION OF HBV PREGENOME RNA PRODUCTION WITH MAINTENANCE OF PRES/S TRNSCRITION IN HDV/HBV CO-INFECTED PATIENTS 56
Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy 56
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial. 56
Immunohistochemical evidence of lactoferrin in hepatic biopsies of patients with viral or cryptogenetic chronic liver disease 55
What is the clinical relevance of portal hypertensive gastropathy (PHG) in patients with compensated liver cirrhosis? 55
Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles. 55
Flavocoxid exerts a potent antiviral effect against hepatitis B virus. 55
APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I/C-III GENETIC POLYMORPHISMS AND CORONARY HEART-DISEASE IN DIABETES-MELLITUS 54
Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease 54
Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study 54
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents. 54
Occult hepatitis B virus infection predicts non-alcoholic steatohepatitis in severely obese individuals from Italy 54
Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta superinfection. 53
Correlates of total homocysteine plasma concentration in type 2 diabetes 53
Control of cccDNA function in hepatitis B virus infection. 53
Risk of occult hepatitis B virus infection reactivation in patients with solid tumours undergoing chemotherapy 53
ABNORMAL ALANINE AMINOTRANSFERASE ACTIVITY REFLECTS EXPOSURE TO HEPATITIS-C VIRUS IN HEMODIALYSIS-PATIENTS 52
Efficacy of high dose of recombinant alpha 2b interferon on long term response in chronic hepatitis C and cirrhosis: prospective randomized multicentre study 52
Hepatitis B e antigen detection in formalin-fixed liver biopsy specimens. A tool to investigate wild-type and E-minus variant HBV infection. 52
High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. 52
Associazione del polimorfismo MTHFR C677T con i livelli plasmatici di omocisteina nel diabete mellito di tipo 2: un effetto modulato dai folati e dal sesso 52
Infezione occulta da virus dell’epatite B in pazienti con epatite cronica virus con correlata valutazione istologica 52
Hepatitis B virus and hepatitis C virus dual infection. 52
NS3 Q80K Polymorphism in viral isolates from Liver Tissues and serum samples of naive HCV genotype 1a Patients 52
Behaviour of occult HBV infection in HCV-infected patients under treatment with direct-acting antivirals 52
Factors affecting diabetes mellitus onset in cystic fibrosis: Evidence from a 10-year follow-up study 52
Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones 51
Hepatitis B virus (HBV) induces the expression of interleukin-8 that in turn reduces HBV sensitivity to interferon-alpha. 51
Evaluation of liver enzyme levels and identification of asymptomatic liver disease patients in primary care 51
determinants of total homocysteine plasma levels in type 2 diabetes 51
The HCV Sicily Network: A web-based model for the management of HCV chronic liver diseases 51
Totale 6.837
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.765
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.765
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201941 0 0 0 0 0 0 0 0 0 21 8 12
2019/20201.679 222 101 18 83 15 146 198 182 45 327 296 46
2020/20211.646 156 27 381 75 143 147 60 225 70 180 108 74
2021/20221.642 20 153 48 58 95 33 126 58 29 281 218 523
2022/20234.536 334 464 225 324 308 452 81 245 1.900 31 133 39
2023/20241.054 81 185 57 105 100 197 19 249 6 55 0 0
Totale 11.800